3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
5
Thoracic
4
Gastrointestinal
3
Gynecologic
2
Genitourinary
2
Dermatologic
2
Breast
2
Sarcoma
1
Other solid neoplasm
1
Lymphoid
1
Conditions
Hodgkin Disease
36
Lymphoma
34
Lymphoma, Non-Hodgkin
24
Lymphoma, Large B-Cell, Diffuse
24
Lymphoma, Follicular
18
Lymphoma, B-Cell
16
Recurrence
15
Melanoma
14
Neoplasms
12
Mycosis Fungoides
9
Lymphoma, T-Cell
9
Breast Neoplasms
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Carcinoma, Non-Small-Cell Lung
8
Squamous Cell Carcinoma of Head and Neck
7
Lymphoma, T-Cell, Cutaneous
7
Lymphoma, B-Cell, Marginal Zone
7
Head and Neck Neoplasms
7
Sezary Syndrome
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Lymphoma, Mantle-Cell
6
Lung Neoplasms
6
Carcinoma, Renal Cell
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Neoplasm Metastasis
5
Lymphoma, T-Cell, Peripheral
5
Waldenstrom Macroglobulinemia
4
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Interventions
pembrolizumab
1
Surveys and Questionnaires
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Imatinib Mesylate
1
GSK-3326595
1
Drug Therapy
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
pembrolizumab
×
Lymphoid
×
Clear all
NCT02783300
2025-03-10
Meteor 1
GlaxoSmithKline
Phase 1
Completed
297 enrolled
76 charts